● Recruiting

Safety and Efficacy of Balloon Pulmonary Angioplasty in China

Condition: Chronic Thromboembolic Pulmonary Hypertension · Sponsor: Chinese Pulmonary Vascular Disease Research Group

PhaseN/A

Planned participants200

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Balloon pulmonary angioplasty (BPA) is a potential treatment for non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to evaluate the safety and efficacy of BPA in CTEPH patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA.

This description comes directly from the study's public registry record.

Talk to the study team

Zhihong Liu, doctor · 86-010-88396589 · zhihongliufuwai@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

center of pulmonary vascular disease, Fuwai hospital	Beijing, China	Recruiting
Chinese Academy of Medical Sciences Fuwai hospital	Beijing, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04206852